Should optimal supportive care alone be the standard of care for brain metastases patients from non-small cell lung cancer, who are not eligible for radiosurgery or surgery?
Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?
Routine prophylactic drainage in rectal surgery—closing the chapter?
Tumor treating fields—effective, but at what cost?
Relapsed small cell lung cancer: is more better?
JMJD3 histone demethylase—a potential therapeutic target for metastatic hepatocellular carcinoma?
Is combined chemotherapy with cisplatin, etoposide and irinotecan the new standard treatment for patients with sensitive relapsed small cell lung cancer?
Hypofractionated radiotherapy for breast cancer: how to evaluate chronic toxicity and cosmesis?
Omission of adjuvant radiotherapy in early-stage breast cancer: have we identified a subgroup?
Micropapillary urothelial carcinoma: is molecular hair-splitting on target?
Distinct benefit from crizotinib in lung cancer patients carrying distinct ALK translocations: is fluorescent hybridization in situ testing still sufficient to guide clinical decisions?
Transgenic mouse models of Idh-mutated neural stem cells: an appropriate model for low grade glioma?
Adding chemotherapy to TKI: can we improve first-line treatment for EGFR-mutated NSCLC patients?
How far have we achieved by systemic therapy for recurrent/metastatic nasopharyngeal carcinoma?
A new approach to high risk pediatric acute lymphoblastic leukemia?
Rac1 and EMT: a dangerous liaison?